Recent Performance of Redhill Biopharma Ltd. ADR (RDHL) Stock: A Closer Look

Ulysses Smith

At the time of writing, Redhill Biopharma Ltd. ADR [RDHL] stock is trading at $1.36, up 3.82%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RDHL shares have gain 7.09% over the last week, with a monthly amount glided 12.86%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Redhill Biopharma Ltd. ADR [NASDAQ: RDHL] stock has seen the most recent analyst activity on August 31, 2021, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $22. Previously, H.C. Wainwright started tracking the stock with Buy rating on May 18, 2021, and set its price target to $23. On September 11, 2020, BTIG Research initiated with a Buy rating. WBB Securities upgraded its rating to a Strong Buy. WBB Securities upgraded its rating to a Buy. Nomura started tracking with a Buy rating for this stock on January 26, 2018, and assigned it a price target of $18. In a note dated October 06, 2017, Seaport Global Securities initiated an Buy rating and provided a target price of $19 on this stock.

For the past year, the stock price of Redhill Biopharma Ltd. ADR fluctuated between $0.90 and $6.80. Redhill Biopharma Ltd. ADR [NASDAQ: RDHL] shares were valued at $1.36 at the most recent close of the market.

Analyzing the RDHL fundamentals

Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -1.1%, Pretax Profit Margin comes in at -0.98%, and Net Profit Margin reading is -0.98%. To continue investigating profitability, this company’s Return on Assets is posted at -0.51, Equity is 2.05 and Total Capital is 2.7. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.05.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.

Ratios To Look Out For

It is important to note that Redhill Biopharma Ltd. ADR [NASDAQ:RDHL] has a current ratio of 0.56. As well, the Quick Ratio is 0.42, while the Cash Ratio is 0.13.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.